Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol ®, ticlopidine, or sulodexide.

CONCLUSIONS: Pycnogenol® is the only product able to control edema and this may reduce the incidence of recurrent RVT. This retrospective registry indicates that Aspirin, Pycnogenol®, ticlopidine an sulodexide reduce recurrent RVT without side effects. Larger studies should be planned to involve a wider range of conditions, diseases and risk factors associated with RVT and to its recurrence. PMID: 30964246 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30964246?dopt=Abstract

Source: Minerva Cardioangiologica - April 11, 2019 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research